Brief: Kalvista Pharmaceuticals Inc - FDA Approves Kalvista's Ekterly For Hereditary Angioedema
10/07/2025 12:31
July 10 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O: KALVISTA PHARMACEUTICALS INC - FDA APPROVES KALVISTA'S EKTERLY FOR HEREDITARY ANGIOEDEMA Source text: ID:nBw8KVW8Ka Further company coverage: KALV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy